Cleared Traditional

K820569 - IVAC #1160 MULTIPLE VITAL SIGNS UNIT

K820569 is the FDA 510(k) clearance for IVAC #1160 MULTIPLE VITAL SIGNS UNIT by Y. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 16-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1982
Decision
16d
Days
Class 2
Risk

K820569 is an FDA 510(k) clearance for the IVAC #1160 MULTIPLE VITAL SIGNS UNIT. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Y (Mchenry, US). The FDA issued a Cleared decision on March 18, 1982 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Y devices

Submission Details

510(k) Number K820569 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 1982
Decision Date March 18, 1982
Days to Decision 16 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
109d faster than avg
Panel avg: 125d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 536
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K820569.
LIFESTAT 200
K831232 · Physio-Control Corp. · Jul 1983
DINAMAP VITAL SIGNS MONITOR #1846
K831515 · Critikon Company, LLC · Jun 1983
CNIBP BLOOD PRESSURE MEASUREMENT SYS
K822055 · Ohio Medical Products · Nov 1982
TAYLOR & TYCOS ACOUSTIC SPHYGMOMANOMETER
K820135 · Sybron Corp. · Mar 1982
DIGITAL BLOOD PRESSURE UNIT
K813385 · Conphar, Inc. · Jan 1982
DINAMAP ADULT/PED./NEONATAL VITAL SIGNS
K813527 · Critikon Company, LLC · Jan 1982